Fresenius Medical Care AG (FMS)
19.28
-0.08
(-0.41%)
USD |
NYSE |
Mar 28, 16:00
19.26
-0.02
(-0.10%)
After-Hours: 20:00
Fresenius Medical Care Enterprise Value: 19.68B for March 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 28, 2024 | 19.68B |
March 27, 2024 | 19.73B |
March 26, 2024 | 19.47B |
March 25, 2024 | 19.47B |
March 22, 2024 | 19.37B |
March 21, 2024 | 19.55B |
March 20, 2024 | 19.91B |
March 19, 2024 | 19.83B |
March 18, 2024 | 19.54B |
March 15, 2024 | 19.54B |
March 14, 2024 | 19.89B |
March 13, 2024 | 20.15B |
March 12, 2024 | 20.18B |
March 11, 2024 | 20.15B |
March 08, 2024 | 20.31B |
March 07, 2024 | 20.49B |
March 06, 2024 | 20.13B |
March 05, 2024 | 20.55B |
March 04, 2024 | 19.32B |
March 01, 2024 | 19.73B |
February 29, 2024 | 19.64B |
February 28, 2024 | 19.70B |
February 27, 2024 | 19.88B |
February 26, 2024 | 19.92B |
February 23, 2024 | 19.74B |
Date | Value |
---|---|
February 22, 2024 | 19.85B |
February 21, 2024 | 19.71B |
February 20, 2024 | 20.47B |
February 16, 2024 | 20.76B |
February 15, 2024 | 20.72B |
February 14, 2024 | 20.81B |
February 13, 2024 | 20.18B |
February 12, 2024 | 20.11B |
February 09, 2024 | 19.84B |
February 08, 2024 | 19.94B |
February 07, 2024 | 19.92B |
February 06, 2024 | 20.02B |
February 05, 2024 | 19.75B |
February 02, 2024 | 19.71B |
February 01, 2024 | 19.91B |
January 31, 2024 | 19.69B |
January 30, 2024 | 19.77B |
January 29, 2024 | 20.15B |
January 26, 2024 | 20.15B |
January 25, 2024 | 20.02B |
January 24, 2024 | 20.07B |
January 23, 2024 | 19.84B |
January 22, 2024 | 19.93B |
January 19, 2024 | 19.84B |
January 18, 2024 | 19.74B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.64B
Minimum
Oct 10 2022
37.33B
Maximum
Jul 29 2020
28.07B
Average
29.78B
Median
Enterprise Value Benchmarks
Biodexa Pharmaceuticals Plc | 0.2488M |
NuCana PLC | -8.464M |
Bicycle Therapeutics PLC | 447.49M |
Biophytis SA | 6.682M |
TC BioPharm (Holdings) PLC | -1.080M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 202.38M |
Revenue (Quarterly) | 5.371B |
Total Expenses (Quarterly) | 4.690B |
EPS Diluted (Quarterly) | 0.3446 |
Gross Profit Margin (Quarterly) | 27.06% |
Profit Margin (Quarterly) | 3.77% |
Earnings Yield | 4.77% |
Operating Earnings Yield | 14.67% |
Normalized Earnings Yield | 5.168 |